Apricoxib
Tools
Actions
General
Print/export
Print/export
In other projects
Appearance
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Vanished user 0x8cSXE0x6 (talk | contribs) at 02:40, 3 July 2015. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 02:40, 3 July 2015 by Vanished user 0x8cSXE0x6 (talk | contribs)
![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C19H20N2O3S |
Molar mass | 356.4387 g/mol g·mol−1 |
3D model (JSmol) | |
|
Apricoxib is an experimental anticancer drug in Phase II clinical trials. It is a COX-2 inhibitor which improves standard therapy response in molecularly defined models of pancreatic cancer.[1]
See also
References
- ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1158/1078-0432.CCR-12-0453, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1158/1078-0432.CCR-12-0453
instead.
![]() | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
Retrieved from "https://en.wikipedia.org/w/index.php?title=Apricoxib&oldid=669723963"
Hidden categories:
- Chem-molar-mass both hardcoded and calculated
- Infobox-drug molecular-weight unexpected-character
- Pages using infobox drug with unknown parameters
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- All stub articles